Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Closed-loop penicillin delivery using electrochemical biosensors
NCT04053140Phase 1Completed
- Sponsor
- Imperial College London
- Start
- Nov 2019
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of benzylpenicillin in bacterial infection, sponsored by Imperial College London. Primary endpoints: Assessment of the biosensors ability to track benzylpenicillin concentrations at 12 hours and Pharmacokinetic-pharmacodynamic target attainment at 12 hours. Started Nov 2019; status: completed.
02
Drugs
benzylpenicillin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04053140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04053140.